Used in pharmaceutical research as a chiral building block for synthesizing biologically active compounds. Its structure supports the development of central nervous system agents, particularly in the design of serotonin and dopamine receptor modulators. Commonly employed in the synthesis of drug candidates targeting neurological disorders such as depression, anxiety, and schizophrenia. Also utilized in the preparation of kinase inhibitors for potential oncology applications. The presence of both pyrrolidine and morpholine rings enhances solubility and binding affinity in drug molecules.